A phase 2 clinical trial in United States in human patients to treat early-to-mid stage Androgenetic Alopecia in men and women

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Mar 2024 New trial record
08 Mar 2024 According to a Stemson media release, today announced an agreement securing Stemson the exclusive global rights to research, develop and commercialize hair regeneration therapeutic products based on Aderans' proprietary hair regeneration cell therapy technology.
08 Mar 2024 According to a Stemson media release, company will resume Aderans' Phase 2 clinical stage cell therapy hair regeneration program.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com